Search
BMS-863233
go.drugbank.com/drugs/DB12357InvestigationalBMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.
Oglemilast
go.drugbank.com/drugs/DB12375InvestigationalOglemilast has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive.
Lisofylline
go.drugbank.com/drugs/DB12406InvestigationalLisofylline has been investigated for the treatment of Type 1 Diabetes Mellitus.
Methyl pyrrolidone
go.drugbank.com/drugs/DB12521InvestigationalN Methyl Pyrrolidone is under investigation for the treatment of Multiple Myeloma.
GSK-1292263
go.drugbank.com/drugs/DB12627InvestigationalGSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2.
Cetilistat
go.drugbank.com/drugs/DB06586InvestigationalCetilistat is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.
PV903
go.drugbank.com/drugs/DB05163ExperimentalPV903 is a self administered vaginally delivered recombinant protein for the treatment of recurrent miscarriage, resulting from an intolerant immune response to the developing foetus.
Dioxybenzone
go.drugbank.com/drugs/DB11221ApprovedWithdrawnDioxybenzone, or benzophenone-8, is an organic compound derived from [DB01878] that is used as a sunscreen agent. It absorbed UV-B and UV-AII rays.
Methapyrilene
go.drugbank.com/drugs/DB04819ApprovedWithdrawnMethapyrilene, formerly marketed in many drug products, was shown to be a potent carcinogen. Manufacturers voluntarily withdrew methapyriline drug products from the market in May and June 1979.
Categories: Antihistamines for Systemic UseClenoliximab
go.drugbank.com/drugs/DB06241ExperimentalIt has investigated for the treatment of rheumatoid arthritis.